Sonrgy grabs rights to UCSD-created ultrasound-nanocarrier tech

San Diego drug delivery company Sonrgy snagged exclusive rights to an ultrasound-based nanotech delivery platform conceived at the University of California, San Diego. The license gives Sonrgy global development and marketing rights to the technology, which uses a focused beam of ultrasound to release drugs at the site of a tumor, which are themselves delivered by nanocarriers. According to a statement from Sonrgy Chief Technology Officer Michael Benchimol, "the SonRx technology addresses long-standing challenges related to stability and controlled release in nanoscale drug delivery." Release

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…